Modulation of guanosine triphosphatase activity of G proteins by arachidonic acid in rat Leydig cell membranes by Marinero Ramos, María Jesús et al.
Endocrinology 2000 141: 1093-1099, doi: 10.1210/en.141.3.1093 
 
M. Jesús Marinero, Santiago Ropero, Begoña Colás, Juan C. Prieto and M. Pilar López-Ruiz 
 
 Acid in Rat Leydig Cell Membranes
Modulation of Guanosine Triphosphatase Activity of G Proteins by Arachidonic
Society please go to: http://endo.endojournals.org//subscriptions/ 
 or any of the other journals published by The EndocrineEndocrinologyTo subscribe to 
 Copyright © The Endocrine Society. All rights reserved. Print ISSN: 0021-972X. Online
Modulation of Guanosine Triphosphatase Activity of
G Proteins by Arachidonic Acid in Rat Leydig
Cell Membranes*
M. JESU´S MARINERO, SANTIAGO ROPERO, BEGON˜A COLA´S, JUAN C. PRIETO,
AND M. PILAR LO´PEZ-RUIZ
Unidad de Neuroendocrinologı´a Molecular, Departamento de Bioquı´mica y Biologı´a Molecular,
Universidad de Alcala´, E-28871 Alcala´ de Henares-Madrid, Spain
ABSTRACT
Previous results from our group have indicated that arachidonic
acid decrease cAMP production through a modification of heterotri-
meric G proteins. In the present study, we have characterized the high
affinity GTPase activity present in Leydig cell membranes and its
regulation by fatty acids. The high-affinity GTPase activity, mea-
sured as [g32P] GTP hydrolysis rate, was both time and protein con-
centration dependent. Arachidonic acid elicited a dose-dependent in-
hibition of enzyme activity with an IC50 5 26.7 6 1.1 mM. The
existence of only two double bonds in linoleic acid is reflected by a
decrease in its inhibitory activity (IC50 5 34 6 2.3 mM). Saturated fatty
acids showed no effect at this level. The kinetic analysis as interpreted
by Lineweaver-Burk plots, indicated that 50 mM arachidonic acid had
no effect on the apparent affinity for GTP, but resulted in a 40%
decreases in the maximal velocity of the reaction. Arachidonic acid
modulation of GTPase activity was not attenuated by blocking eico-
sanoid metabolism with inhibitors of 59-lipoxygenase, cyclooxygen-
ase, or epoxygenase P-450. The addition of arachidonic acid to per-
tussis toxin-treated membranes had no effect on the enzyme activity,
indicating that arachidonic acid does not modify the GTPase activity
present in Gas protein. However, ADP-ribosylation with cholera toxin
followed by arachidonic acid treatment led to a further 40% inhibition
when compared with cholera toxin treatment alone. These results
allowed us to postulate that arachidonic acid inhibits the GTPase
activity of Gi protein family. To further analyze the mechanism of
arachidonic acid inhibition of GTPase activity, the effect of arachi-
donic acid on the [35S]GTPgS binding was studied. No effect of this
fatty acid on GTP binding was found. Combining our previous results
with those found here, we can conclude that arachidonic acid main-
tains Gi proteins in their active state, which in turn inhibit adenylate
cyclase and results in decrease cAMP levels. (Endocrinology 141:
1093–1099, 2000)
MOST OF the biological functions of unsaturated fattyacids are due to their ability to act as second mes-
sengers or modulators of the activities of functionally im-
portant proteins. Fatty acids can act on signal transduction
pathways by direct and/or indirect means. However, several
studies clearly show that fatty acids per se are messenger and
modulator molecules that can mediate cell responses to ex-
tracellular signals (1). Arachidonic acid (AA), which is es-
terified to the sn-2 position of membrane phospholipids, is
mainly released from phospholipids by activation of phos-
pholipase A2 (PLA2). It can be also produced by activation of:
phospholipase C (PLC) followed by diacylglycerol hydroly-
sis by diacylglycerol lipase; phospholipase D (PLD) followed
by phosphatidic acid phosphohydrolase and diacyl glycerol
lipase; and finally, phospholipase A1 (PLA1) followed by
lysophospholipase (2).
In Leydig cells, steroidogenesis is regulated by LH, via
cAMP and other second messengers such as calcium, chlo-
ride ions, and arachidonic acid and/or its metabolites (3, 4).
Recent results have shown that LH causes a dose- and time-
dependent release of arachidonic acid from Leydig cells (5).
Furthermore, arachidonic acid itself has been reported to act
as an additional intracellular messenger associated with the
hormonal action of LH (6–8). Previous results from our
group have shown that in rat Leydig cells that arachidonic
acid exerts a dose- and time-dependent biphasic effect on
LH- and dibutryl-cAMP-stimulated testosterone production
(9). During short periods of incubation this fatty acid inhibits
testosterone synthesis by decreasing cAMP levels. Recently,
we have shown that arachidonic acid can modulate cAMP
production through a modification of heterotrimeric G pro-
teins which occurs mainly by activation of Gi protein (10).
It is well known that G proteins are comprised of three
polypeptides: an a subunit that binds and hydrolyzes GTP,
a b subunit, and a g subunit. The b and g subunit form a
dimer that only dissociates when it is denatured and is,
therefore, a functional monomer. When GDP is bound, the a
subunit associates with the bg complex and forms an inactive
heterotrimer that binds to the receptor. When the hormone
binds to the receptor, specific types of G proteins become
activated by promoting the exchange of tightly bound GDP
for GTP. Once GTP is bound, the a subunit assumes its active
conformation and dissociates both from the receptor and
from the bg complex. The activated state persists until GTP
is hydrolyzed to GDP by the action of the intrinsic GTPase
activity of the a subunit. Once GTP is cleaved to GDP, the a
and bg subunit reassociate, become inactive and return to the
receptor (11). Considering that the active lifetime of G pro-
teins depends on the rate of GTP hydrolysis, the aim of the
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present work was to determine if the effect of arachidonic
acid on G proteins is due to a modification of its GTPase
activity
Materials and Methods
DMEM was obtained from Life Technologies, Inc. (Middlesex, UK).
Collagenase (Type I) was purchased from Worthington Biochemical
Corp. (Freehold, NJ). Arachidonic acid (free acid, sealed ampoule), li-
noleic acid (sealed ampoule), stearic acid (free acid), BSA (essentially
fatty acid free) (BSA-FAF), ATP, GTP, creatine kinase, creatine phos-
phate, Percoll, trypsin inhibitor (1% sterile-filtered solution) indometh-
acin, nordihydroguaiaretic acid (NDGA), clotrimazole, pertussis toxin
(PTX), and cholera toxin (CTX), were purchased from Sigma Quı´mica
(Alcobendas, Spain). [g32P] GTP and [35S]GTPgS were obtained from
NEN Life Science Products (Madrid, Spain). All other chemicals used
were of analytical reagent grade.
Cell isolation and purification
Leydig cells were isolated from 200–300 g Sprague Dawley rats from
the Animal House of the University of Alcala. All animals were cared
for according to the guidelines of the University Committee of Animal
Resources at the University of Alcala´. The testes were decapsulated and
subjected to longitudinal shaking (65 strokes/min) with collagenase (0.5
mg/ml) and trypsin inhibitor (20 ml/ml) for 40 min at 37 C. The cells
were filtered through 60 mm nylon gauze to remove fragments of sem-
iniferous tubules and subjected to centrifugal elutriation followed by
Percoll density gradient (0–90% vol/vol) centrifugation (12). Leydig cell
purity was routinely .95%, as determined by 3b-hydroxysteroid de-
hydrogenase cytochemistry (12).
Membrane preparation
Purified Leydig cells were disrupted by freeze-thawing (4 times) in
a buffer containing Tris-HCl 50 mm, pH 7.5, 3 mm EDTA, 5 mg/ml
soybean trypsin inhibitor, and 0.1 mm phenylmethylsulfonyl fluoride.
Broken cells were centrifuged at 400 3 g for 2 min. at 4 C and the
supernatant was centrifuged at 100,000 3 g for 15 min at 4 C. The final
pellet containing the crude plasma membranes were suspended in the
same buffer and 50 ml aliquots were stored at 270 C.
Toxin treatments (PTX and CTX)
For in vitro ADP ribosylation, the toxins were activated by incubation
with 100 mm DTT for 30 min at 37 C. Activated toxins were diluted in
ribosylation buffer as described in Ref. 13 with 5 mm NAD. Samples
were exposed to the toxins, 0.125 mg PTX per 1.5 mg proteins and 0.3 mg
CTX per1.5 mg proteins for 30 min at 30 C, before performing the GTPase
assays. The time course of ribosylation was followed with [32P]NAD in
the presence of PTX or CTX as described previously (13). Labeled pro-
teins were separated on SDS/PAGE gels, dried, and autoradiography
was performed by exposing the gels to x-ray film. The results of these
experiments indicated that a 41 kDa band was maximally labeled at 30
min with PTX treatment. At this same time, two bands with molecular
weights of 50 and 52 kDa were maximally labeled with CTX and were
chosen for subsequent ribosylation experiments (data not shown).
GTPase assay
Hydrolysis of [g32P]GTP was measured essentially as described by
Schepers et al. (14). Briefly, the reaction mixture (70 ml) contains: 50 mm
triethanolamine-HCl, pH 7.4, 1 mm dithiothreitol, 1 mm EDTA, 5 mm
MgCl2, 100 mm ATP, 100 mm NaCl, 0.4 mg/ml creatine kinase, 5 mm
creatine phosphate, 2 mg/ml BSA, 1 mm ouabain, 200 nm GTP, and 30
nm [g-32P] GTP plus 10 ml of the appropriate concentration of fatty acid
or vehicle. The reaction was initiated by the addition of 20 ml of mem-
brane protein (1.5 mg) to each tube (except the protein concentration
experiments). The reaction was carried out at 30 C for 10 min (except for
the time-course experiments) and terminated by the addition of 700 ml
of ice cold activated charcoal (5% in 20 mm phosphoric acid, pH 2.5) after
10 min at 4 C. Assay tubes were centrifuged for 15 min at 4 C at 3,000 3
g. Radioactivity in the supernatant was assayed by liquid-scintillation
counting to determine the release of 32Pi. Low-affinity hydrolysis of
[g-32P] GTP was assessed by parallel incubation of membranes with
excess (250 mm) GTP. The low-affinity activity was subtracted from the
total to calculate high-affinity GTPase activity. Results were expressed
as pmol of Pi released per min per mg protein.
GTPgS binding assay
Guanine nucleotide binding by G protein a subunit was determined
by incubating membranes (2 mg of proteins) in 100 ml total volume of 50
mm Tris-HCl, pH 7.4, 100 mm NaCl, 1 mm DTT, 5 mm MgCl2, 1 mm
EDTA, 0.1 mm [35S]GTPgS, and increasing concentrations of unlabeled
GTPgS. The reaction was carried out at 30 C for 45 min (equilibrium
conditions), and samples were filtered through a Whatman GF/C filter,
and washed with ice-cold (2 3 2 ml) buffer consisting of 50 mm Tris-HCl
pH 7.4, 5 mm MgCl2. Nonspecific binding to proteins, assessed by
quantitating the binding in the presence of 100 mm unlabeled GTPgS,
was subtracted from each value to calculate the specific binding. The
radioactivity bound to the filter was measured by liquid scintillation
counting. The results were expressed as GTP bound (% of total radio-
activity added).
The protein concentrations were determined by the method of Brad-
ford (15), using BSA as a standard.
All data are expressed as mean 6 sem from, at least, three experi-
ments, each of which was performed in duplicate. Each experiment is
carried out with membranes obtained from a new isolation. Student’s t
test was used for statistical analysis and differences were considered
significant when P , 0.05
Results
Characterization of G protein-linked GTPase activity in
Leydig cell membranes
The high-affinity GTPase activity was determined by mea-
suring the amount of 32P released at 30 C following incuba-
tion for different time periods. The GTPase reaction was
found to be linear for 15 min. (Fig. 1A). There was also a linear
relationship between membrane protein and GTP hydrolysis
up to concentrations of 2 mg of membrane protein, reaching
a plateau with higher protein concentrations and 10 min
incubation times (Fig. 1B). Based on these findings, subse-
quent experiments were carried out using 1.5 mg of protein
and an incubation time of 10 min. Under these conditions, the
basal activity was about 50 pmol per min per mg protein.
Arachidonic acid inhibition of high-affinity GTPase activity
Leydig cell membranes were preincubated with arachi-
donic acid (1, 50, and 100 mm) for different time periods (1–10
min) and GTPase activity was determined. As illustrated in
Fig. 2A, there was a time-dependent inhibition of GTPase
activity both at 50 mm and 100 mm arachidonic acid. No
inhibitory effect was found with 1 mm arachidonic acid at any
of the preincubation times assayed. One minute of preincu-
bation with 100 mm arachidonic acid produced approxi-
mately a 50% inhibition of the GTPase activity, whereas 2.5
min was necessary to obtain the same level of inhibition
when 50 mm of the fatty acid was used. A 60.5 6 3.7% (n 5
18) inhibition of GTPase activity was obtained when the
membranes were preincubated for 5 min with 50 mm ara-
chidonic acid and these conditions were used for the sub-
sequent experiments. The dose response effect of arachidonic
acid on GTPase activity was studied using doses between 1
and 100 mm and 5 min of preincubation (Fig. 2B). This fatty
acid inhibited the high-affinity GTPase activity in a concen-
1094 AA MODULATES GTPase ACTIVITY OF G PROTEINS Endo † 2000
Vol 141 † No 3
tration-dependent manner with an IC50 value of 26.7 6 1.1
mm. The kinetic analysis of the high-affinity GTPase activity,
and its modification by arachidonic acid, was performed by
employing Lineweaver-Burk plots of the data obtained as a
function of GTP concentrations. A linear relationship obtain-
ing a maximum velocity (Vmax) of 3.06 6 0.3 nmol per min
per mg protein was observed. A Michaelis Menten constant
value (KM) of 3.36 6 0.48 mm for control membranes was also
observed. Arachidonic acid at a concentration of 50 mm, had
no effect on the apparent affinity (KM 5 3.45 6 0.24 mm), but
produced a 40% of reduction of the maximal velocity (Vmax
5 1.88 6 0.15 nmol per min per mg protein (Fig. 3).
Arachidonic acid modulation of high-affinity GTPase
activity is direct and not mediated via its metabolites
To examine if the inhibition of GTPase activity by arachi-
donic acid is due to the fatty acid itself or to its transformation
to active metabolites, we added inhibitors of the arachidonic
acid metabolizing enzymes, namely: 5 mm indomethacin for
cyclooxygenase, 5 mm NDGA for lipoxygenase, and 5 mm
Clotrimazole for epoxygenase P450 (16) together with ara-
chidonic acid. The high-affinity GTPase activity was inhib-
ited by arachidonic acid (50 mm) by about 60%, and the same
percentage of inhibition was obtained in the presence of
inhibitors of arachidonic acid metabolism. The high-affinity
GTPase activity was similar to control when the three in-
FIG. 1. High-affinity GTP hydrolysis as a function of reaction time
and protein concentration. A, The amount of 32P released from 30 nM
[g32P]GTP was determined after different incubations times at 30 C
with 1.5 mg of protein. B, The amount of 32P released from 30 nM
[g32P]GTP was determined after 10 min of incubation with different
proteins concentrations. The high-affinity GTPase activity was cal-
culated by subtracting the amount of [g32P]GTP hydrolyzed in the
presence of 250 mM unlabeled GTP from the total amount of 32P
released and is expressed as pmol of Pi released/mg protein (A) and
pmol of Pi released/min (B). All data are the mean 6 SEM of three
separate experiments, each of which was performed in duplicate.
Each experiment was carried out with membranes obtained from a
new isolation.
FIG. 2. Arachidonic acid inhibition of high-affinity GTPase activity in
Leydig cell membranes. A, Leydig cell membranes (1.5 mg) were pre-
incubated with arachidonic acid (1, 50, and 100 mM) at indicated time
periods, and the high-affinity GTPase activity was determined after
10 min of incubation. B, Leydig cell membranes (1.5 mg) were pre-
incubated during 5 min with increasing concentrations of arachidonic
acid (1–100 mM), and the high-affinity GTPase activity was deter-
mined after 10 min of incubation. The high-affinity GTPase activity
was calculated by subtracting the amount of [g32P]GTP hydrolyzed in
the presence of 250 mM unlabeled GTP from the total amount of 32P
released and is expressed as pmol of Pi released/min per mg protein.
All data are the mean 6 SEM of four separate experiments, each of
which was performed in duplicate. Each experiment was carried out
with membranes obtained from a new isolation
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hibitors were assayed together without arachidonic acid.
(Fig. 4)
Relationship between the insaturation degree and
GTPase activity
The dose response inhibitory action of arachidonic acid on
GTPase activity was then compared with that of other fatty
acids having different degrees of unsaturation, mainly lino-
leic acid (18:2) and stearic acid (18:0). Arachidonic acid was
the most potent inhibitor of GTPase activity with an IC50 5
26.7 6 1.1 mm. For linoleic acid, the possession of only two
double bonds, was apparently reflected in its diminished
activity (IC50 5 34.0 6 2.3 mm). Stearic acid with no double
bounds, showed little effect on high-affinity GTPase activity,
suggesting a role for the degree of unsaturation in the inhi-
bition of GTPase activity (Fig. 5).
Arachidonic acid modulates GTPase activity of Gi proteins
We then studied the modification of GTPase activity
after treatment of membranes with pertussis toxin (PTX).
This toxin catalyzes the ADP-ribosylation of a specific
cysteine residue in the Gai family. This covalent modifi-
cation inactivates these ai-subunits, such that they cannot
exchange GDP for GTP (17). Under these conditions, the
GTPase activity detected in the assay is only due to PTX-
insensitive G proteins. In fact, the GTPase activity present
in PTX-treated membranes was about 30% lower than that
found in the control. The addition of arachidonic acid to
PTX-treated membranes had no effect on the enzyme ac-
tivity, a clear indication that arachidonic acid does not
modify the GTPases activity present in PTX-insensitive G
proteins such as Gas proteins (Fig 6). To analyze the in-
volvement of Gi proteins in arachidonic acid action, we
studied the GTPase activity after treatment of membranes
with cholera toxin (CTX), which catalyzes the ADP-ribo-
sylation of a specific arginine residue in Gas family (17).
This covalent modification inhibits the intrinsic GTPase
activity of these as-subunits so that, under these condi-
tions, the GTPase activity detected in the assay is only due
to CTX-insensitive G proteins (Gai proteins). As shown in
Fig. 6, ADP-ribosylation with CTX followed by arachi-
donic acid treatment, led to a 40% of inhibition when
compared with CTX-treatment alone. These results clearly
indicate that arachidonic acid inhibits the GTPase activity
of the Gi family of proteins.
FIG. 3. Effect of arachidonic acid on Vmax and KM values of high-
affinity GTPase activity. Leydig cell membranes (1.5 mg) were pre-
incubated during 5 min with arachidonic acid (50 mM) and the high-
affinity GTPase activity was determined in the presence of increasing
concentrations of GTP (0.2–10 mM) after 10 min of incubation. The
high-affinity GTPase activity was calculated by subtracting the
amount of [g32P]GTP hydrolyzed in the presence of 250 mM unlabeled
GTP from the total amount of 32P released and is expressed as pmol
of Pi released/min per mg protein. The data were analyzed by
Lineweaver-Burk plot to determine the kinetic parameters. All data
are the mean 6 SEM of six separate experiments, each of which was
performed in duplicate. Each experiment was carried out with mem-
branes obtained from a new isolation
FIG. 4. Effect of inhibitors of arachidonic acid metabolism on the
activity of the fatty acid. Leydig cell membranes (1.5 mg) were pre-
incubated during 5 min with reaction mixture alone (control) or ar-
achidonic acid (50 mM) in the presence and absence of arachidonic
metabolism inhibitors, and the high-affinity GTPase activity was
determined after 10 min of incubation. The high-affinity GTPase
activity was calculated by subtracting the amount of [g32P]GTP hy-
drolyzed in the presence of 250 mM unlabelled GTP from the total
amount of 32P released and is expressed as pmol of Pi releasedzmin21
per mg protein. All data are the mean 6 SEM of four separate exper-
iments, each of which was performed in duplicate. Each experiment
was carried out with membranes obtained from a new isolation
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Lack of effect of arachidonic acid on GTPgS binding
The inhibitory effect of arachidonic acid on GTPase activ-
ity might be due to either direct effects on the intrinsic
GTPase itself, or a decrease in GTP binding. To test this
second possibility, we studied the [35S]GTPgS binding in
Leydig cell membranes. Under optimized conditions, GTPgS
binding was linear up to a protein concentration of 5 mg/tube
and was also time dependent (at 30 min; data not shown).
Increasing concentrations of GTP competitively inhibited
[35S]GTPgS binding to membranes and arachidonic acid had
no effect on this binding. Thus, inhibition of GTPase activity
by arachidonic acid cannot be attributable to an inhibition in
GTP binding (Fig. 7).
Discussion
Previous results from our group have indicated that in-
hibition of steroidogenesis by arachidonic acid in Leydig
cells result from a suppression of hormone-stimulated cAMP
levels by activation of Gi proteins (10). In the present work,
we have characterized the high-affinity GTPase activity of G
proteins in Leydig cell membranes and their regulation by
arachidonic acid. Several reports have postulated that ara-
chidonic acid regulates GAP (GTPase activating protein)-
stimulated GTPase activity, with important regulatory effect
on cellular function (18–23). However, little is known about
the regulation of high-affinity GTPase activity by fatty acids.
Our present results clearly indicate that arachidonic acid
produces a time- and dose-dependent inhibition of high-
affinity GTPase activity with an IC50 of 26.7 mm. In fetal
guinea-pig lung membranes, arachidonic acid seems to play
an important role in the developing organ by decreasing
GTPase activity (16), but with a IC50 5 48 mm. In rat and
human islet membranes (24), high arachidonic acid concen-
trations (330 mm) produce insulinotropic effects due, in part,
to its ability to maintain G proteins in their active configu-
ration by decreasing GTP hydrolysis.
It is well know that arachidonic acid acts indirectly via its
metabolites (21), and directly by modulating G protein-me-
diated signals (2, 18, 20). In this context, our results clearly
indicate that the action of arachidonic acid on G proteins in
Leydig cell membranes is direct and not due to its transfor-
mation to its active metabolites, because the inhibitory effect
is not reversed in the presence of arachidonic acid metabo-
lism inhibitors. This is consistent with our previous report
showing that arachidonic acid itself decreases the LH-stim-
ulated cAMP production in Leydig cells (9) and by others,
indicating that unsaturated fatty acids can interact with sig-
naling proteins in vitro and modulate their activities. For
example, arachidonate and related unsaturated fatty acids
physically associate with and inhibits the activity of the Ras
GTPase activating protein known as GAP (20). Such lipids
can also regulate the association of the Ras-related protein,
Rac, with a specific GDP dissociation inhibitor (18). In ad-
dition, an apparent relationship between the potency of fatty
FIG. 5. Specificity of fatty acid-effects on high-affinity GTPase ac-
tivity. Leydig cell membranes (1.5 mg) were preincubated during 5
min with creasing concentrations (1–100 mM) of arachidonic acid (20:
4), linoleic acid (18:2), and stearic acid (18:0), and the high-affinity
GTPase activity was determined after 10 min of incubation. The
high-affinity GTPase activity was calculated by subtracting the
amount of [g32P]GTP hydrolyzed in the presence of 250 mM unlabeled
GTP from the total amount of 32P released and is expressed as pmol
of Pi released/min per mg protein. All data are the mean 6 SEM of four
separate experiments, each of which was performed in duplicate.
Each experiment was carried out with membranes obtained from a
new isolation
FIG. 6. Effect of PTX and CTX pretreatment on control and arachi-
donic acid-modulated high-affinity GTPase activity. Leydig cell mem-
branes (1.5 mg) were preincubated during 30 min with activated PTX
and CTX before treatment during 5 min with arachidonic acid (50 mM).
Control membranes were preincubated in parallel with reaction mix-
ture. High-affinity GTPase activity was determined after 10 min of
incubation. The high-affinity GTPase activity was calculated by sub-
tracting the amount of [g32P]GTP hydrolyzed in the presence of 250
mM unlabeled GTP from the total amount of 32P released and is
expressed as pmol of Pi releasedzmin21 per mg protein. All data are
the mean 6 SEM of four separate experiments, each of which was
performed in duplicate. Each experiment was carried out with mem-
branes obtained from a new isolation
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acid inhibition of GTPase activity and the number of double
bonds in the fatty acid molecule has been noted by other
workers and is consistent with the data presented herein. For
example, when bacterially synthesized c-Ha-ras protein
(Ras) was incubated with GTPase-activating protein in the
presence of saturated or unsaturated fatty acids, 150 mm
arachidonic acid blocked GTPase-activating protein activity
by 88%, whereas linoleic acid (18:2) was 33% inhibitory and
saturated fatty acids (palmitic, stearic) showed no effect at
similar concentrations (20).
The GTPase assay, performed in ADP-ribosylated mem-
branes, clearly indicated that arachidonic acid acts on a CTX-
insensitive (PTX-sensitive) Gi family of proteins. The mech-
anism by which arachidonic acid inhibits GTPase activity is
still not known, but present results indicate that affinity for
GTP is unaffected by arachidonic acid (similar KM). Further-
more, this fatty acid does not affect GTP binding at the
guanine nucleotide-binding pocket of the a-subunit (Fig. 7).
Similarly, Kowluru and Metz (24) found that the inhibition
of GTPase activity in pancreatic islet subcellular fractions by
lipids could not be attributable to a mere reduction of GTPgS
binding. However, arachidonic acid suppresses guanine nu-
cleotide binding to the a-subunit of Gz (22). Our finding of
a significant effect of arachidonic acid (IC50 26.7 mm) at levels
much below the critical micellar concentration for arachi-
donic acid [73 mm (22)] supports the notion that arachidonic
acid interaction with membrane proteins is unlikely to be
micelle-dependent as suggested for arachidonic acid-recom-
binant Gz interaction (22). The precise mechanisms whereby
the FFA affect specific biological functions is at present un-
known. Nevertheless, the concept of membrane lipid struc-
tural heterogeneity, i.e. lipid domains, is now well accepted
(25). The concept that organization of the lipid component of
membranes into domains permits one to postulate that spe-
cific membrane proteins reside in specific lipid domains. It
is reasonable to assume that perturbations of specific domain
structure by arachidonic acid could affect G protein structure
and function, as it has been postulated by others (25, 26).
Previous results from our group have indicated that ara-
chidonic acid inhibits LH-stimulated cAMP production in
Leydig cells (9) by activation of a Gi protein (10). The results
presented in this paper indicate that arachidonic acid inhibits
the GTPase activity of Gi proteins without a modification of
GTP binding. This implies that arachidonic acid maintains Gi
proteins in their activated state, and thereby, are able to
inhibit adenylate cyclase. It is reasonable to postulate that
this could be the molecular mechanism by which arachidonic
acid decreases the LH-stimulated cAMP and testosterone
accumulation previously reported by us (9, 10). It is not
completely clear whether the LH receptor is coupled to Gi,
but several reports have indicated that Gi, in addition to Gs,
may also has a role in the control of Leydig cell cAMP
production (27–29). More recently Rajagopalan-Gupta et al.
(30) have demonstrated that activation of LH receptor pro-
motes activation of Gai in addition to Gas. Therefore, the
present results together with those indicating that arachi-
donic acid is released after LH-receptor interaction (5) clearly
point out the mechanism by which arachidonic acid acts as
a second messenger in steroidogenesis in Leydig cells.
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